144 related articles for article (PubMed ID: 15561342)
21. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
22. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
23. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
[TBL] [Abstract][Full Text] [Related]
24. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
[TBL] [Abstract][Full Text] [Related]
25. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
26. Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy.
Staudt A; Herda LR; Trimpert C; Lubenow L; Landsberger M; Dörr M; Hummel A; Eckerle LG; Beug D; Müller C; Hoffmann W; Weitmann K; Klingel K; Kandolf R; Kroemer HK; Greinacher A; Felix SB
Clin Pharmacol Ther; 2010 Apr; 87(4):452-8. PubMed ID: 20054293
[TBL] [Abstract][Full Text] [Related]
27. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A
Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
[TBL] [Abstract][Full Text] [Related]
28. Mortality benefit of a comprehensive heart failure disease management program in indigent patients.
Hebert KA; Horswell RL; Dy S; Key IJ; Butler MK; Cerise FP; Arcement LM
Am Heart J; 2006 Feb; 151(2):478-83. PubMed ID: 16442918
[TBL] [Abstract][Full Text] [Related]
29. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.
Pankuweit S; Lüers C; Richter A; Ruppert V; Gelbrich G; Maisch B;
Eur J Clin Invest; 2015 Sep; 45(9):906-17. PubMed ID: 26094644
[TBL] [Abstract][Full Text] [Related]
30. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
[TBL] [Abstract][Full Text] [Related]
31. Influence of biventricular pacing on myocardial dispersion of repolarization in dilated cardiomyopathy patients.
Santangelo L; Ammendola E; Russo V; Cavallaro C; Vecchione F; Garofalo S; D'Onofrio A; Calabrò R
Europace; 2006 Jul; 8(7):502-5. PubMed ID: 16760230
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
[TBL] [Abstract][Full Text] [Related]
33. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
[TBL] [Abstract][Full Text] [Related]
34. Clinical profiles and outcomes for Omani children with dilated cardiomyopathy seen in a regional referral hospital.
Jaiyesimi O; Kasem M
Cardiol Young; 2009 Apr; 19(2):145-51. PubMed ID: 19224668
[TBL] [Abstract][Full Text] [Related]
35. Immunoadsorption in patients with dilated cardiomyopathy.
Herda LR; Felix SB; Staudt A
Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
[TBL] [Abstract][Full Text] [Related]
36. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
Ng AC; Sindone AP; Wong HS; Freedman SB
Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
[TBL] [Abstract][Full Text] [Related]
37. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
[TBL] [Abstract][Full Text] [Related]
38. Mitral effective regurgitant orifice area versus left ventricular ejection fraction as prognostic indicators in patients with dilated cardiomyopathy and heart failure.
Venturi F; Gianfaldoni ML; Melina G; Cecchi A; Petix NR; Monopoli A; Taiti A; Mazzoni V; Fantini F
Ital Heart J; 2004 Oct; 5(10):755-61. PubMed ID: 15626272
[TBL] [Abstract][Full Text] [Related]
39. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy.
Blanc JJ; Fatemi M; Bertault V; Baraket F; Etienne Y
Europace; 2005 Nov; 7(6):604-10. PubMed ID: 16216764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
